At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 35 enrolled
Drug / intervention
allopurinol +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Does Allopurinol Prolong a Treated, Acute Gout Flare?
In Brief
A Phase 4 clinical trial evaluating allopurinol and Placebo (sugar pill) for Gout. Completed, enrolled 35 participants across 1 site.
Detailed Summary
This is a double blind placebo controlled study to determine whether starting allopurinol during a treated acute gout attack will have any effect on the duration of the attack.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsGout
CountriesUnited States
CollaboratorsUnited States Air Force
Timeline
Phase 4CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartDec 2007
Primary CompletionJun 2013
First PostedNov 2013
TodayJul 2026
First PostedNov 20, 2013
Enrollment StartDec 1, 2007
Primary CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5.5 yearsPosted 12.6 years ago
Interventions
allopurinoldrug
Placebo (sugar pill)drug